Inhibition in Medical Technology
Navigation Links
Inhibition in Medical Technology
... with methotrexate, experienced a significant inhibition in the progression of structural joint damage ... plus methotrexate experienced a significant inhibition in the progression of structural joint damage, as ... "The findings from these studies relating to the inhibition of IL-6 reinforce ACTEMRA as a viable treatment ...
... of energy expenditure and adiposity. Selective inhibition of FGFR4 with antisense drugs in peripheral ... Booten, B.P. Monia, S. Bhanot. Antisense inhibition of cAMP Response Element Binding Protein (CREB) ... Witchell, P. Manchem, S. Bhanot, B.P. Monia. inhibition of Transthyretin Expression by Antisense ...
... May Have Direct Anti-Tumor and Angiogenesis inhibition Activity New York, London and Bermuda, June ... potential anti-tumor and angiogenesis inhibition effects of XERECEPT(R). "The ability to ... models, in addition to assessment of angiogenesis inhibition potential. These placebo-controlled studies were ...
... a much higher TRAP-induced platelet aggregation inhibition compared to standard of care alone in both ... TRAP-induced platelet aggregation inhibition was also measured. In those receiving the three oral loadings doses, platelet inhibition of greater than or equal to 80 percent was seen ...
... Reversible, High-level Platelet inhibition with Immediate Onset of Action - NEW ORLEANS ... transition to predictable, reversible platelet inhibition in the chronic setting. "Of the millions of ... PRT060128, and achieved the predefined endpoint. inhibition of thrombosis was highly significant in these ...
... patients. Study Results --Leukotriene inhibition The ACS trial demonstrated a statistically ... E4 (LTE4), also showed significant inhibition at all dose levels. The CEA trial confirmed the ... inhibited at 12 weeks (p < 0.001). Leukotriene inhibition was seen early in both trials and was ...
... enhances insulin signaling through potent PTP-1B inhibition both in vivo and in vitro. "The search to ... and safety of MSI-1436 in future studies." inhibition of PTP-1B, a non-receptor isoform of the protein ... obese animal models. The poster described the inhibition of PTP-1B by MSI-1436 as fully reversible and ...
... - First Phase II data investigating the dual inhibition of HER2 and VEGF pathways with two oral, small ... resistance.(4) It is believed that targeted inhibition of several tumor cell signaling pathways may be more effective than inhibition of a single pathway alone.(4) "Targeted ...
... tumors, treatment with PCI-27483 led to inhibition of tumor growth. PCI-27483 was administered twice ... 90 mg/kg, resulting in 42 percent and 85 percent inhibition of tumor growth, respectively, after 15 days of ... Previous work has shown significant growth inhibition in lung and colorectal cancer models. ...
... of HuMax-EGFr (zalutumumab) results in effective inhibition of cancer cell growth. Genmab A/S (OMX: GEN) ... of HuMax-EGFr (zalutumumab) results in effective inhibition of cancer cell growth. As EGFr activity plays ... the structural rearrangement accompanying inhibition of individual EGFr molecules was studied. ...
... but not in normal cells, which then leads to the inhibition of glycolysis selectively in tumor cells. ... within the glycolytic pathway and the inhibition of lactate production. The observed inhibition of glycolysis is a key factor in the energetic ...
... anti-tumor activity through continuous targeted inhibition of mTOR - ... demonstrates the possibilities of continuous mTOR inhibition as a promising target in oncology," said David ... once-daily oral therapy that provides continuous inhibition of mTOR. As an investigational compound, the ...
... inhibition Was Sustained and Dose-Dependent in Sub-Analysis ... dose- dependent, specific agonist-induced inhibition of platelet aggregation in blood samples from ... coronary intervention (PCI). "The inhibition of platelet aggregation plays a critical role ...
... and SF1126, as well as synergistic growth inhibition of brain cancer cells with combinations of ... SF1126 and rapamycin showed excellent growth inhibition synergies across all prostate, renal ... as a single agent showed significant tumor growth inhibition relative to the control group (73% inhibition, p ...
... mice resulted in substantial tumor growth inhibition in a statistically-significant dose-related ... as changes in tumor weight, tumor growth inhibition and tumor regression. In all models, NKTR-102 ... at 90 mg/kg resulted in only modest tumor growth inhibition of 6% in colorectal and 24% in lung. In the ...
... to date demonstrate the potential of simultaneous inhibition of MET, RET, and VEGFR, and validate our ability ... in preclinical models has demonstrated potent inhibition of both MET and VEGFR2. XL184 has also exhibited potent inhibition of other important receptor tyrosine kinases ...
... as a multitargeted compound, directed to the inhibition of key cell signaling pathways involved in tumor ... and spread. Tumor cells are targeted through inhibition of epidermal growth factor receptor (EGFR) and ... while tumor blood supply is targeted through inhibition of vascular endothelial growth factor receptor ...
... selectively targets a subunit of the immunoproteasome, known as LMP7. inhibition of this subunit results in a decrease of the immune cell signaling cascade ... Molineaux, Ph.D., Chief Scientific Officer at Proteolix. "This selective inhibition of the immunoproteasome results in an increased therapeutic margin ...
... outcomes. Pharmacodynamic analysis of tumor tissue confirmed inhibition of the PI3K pathway by complete absence of a downstream target (pS6). In contrast, a normal tissue (skin) demonstrated no inhibition providing evidence of tumor selectivity of SF1126. Pharmacokinetics ...
... in both animal models of ocular disease and in human clinical trials. The inhibition of both TORC1 and TORC2 should result in more complete inhibition of aberrant PI3K/Akt/mTOR signaling and are therefore of active interest ...
... genotype 1. In this study, low doses of ritonavir were used for metabolic inhibition to enhance the levels of SCH 900518 within the body and reduce the ... receiving PEGINTRON/REBETOL combination therapy, weight loss and growth inhibition were common. Patients receiving PEGINTRON and REBETOL as retreatment ...
... for development of a novel therapeutic drug targeting Btk for safe inhibition of B-cell mediated diseases. In preclinical studies, PCI-32765 has the ... is a critical enzyme involved in B-cell activation and function, and inhibition may be useful in the treatment of a number of immune mediated diseases. ...
... small molecule anticancer agent that delivers highly selective and potent inhibition of CK2, a constitutively active protein kinase that is overexpressed in a ... and the data attribute the anti-tumor activity of CX-4945 to intracellular inhibition of the CK2 enzyme. About Cylene Pharmaceuticals, Inc. Cylene ...
... over other anti-platelet agents through immediate, high-level platelet inhibition in the acute setting and a seamless transition to predictable platelet inhibition in the chronic setting. Additionally, due to its reversible binding to ...
... overexpression is a poor prognostic factor. It has been postulated that inhibition of PIM kinase may potentiate the activity of m-tor inhibitors by ... are strong survival factors and can induce progression of the cell cycle, inhibition of apoptosis, and modulation of other signal transduction pathways. ...
... with Dr. Gary Gilkeson's group now show that targeted complement inhibition using TT30 leads to both local control of inflammation as well as a ... in models for several complement-mediated diseases showed that targeted inhibition of the alternative complement pathway slowed or halted disease progression ...
... was rapidly absorbed and exposures were related to dose. Dose-dependent inhibition of serotonin-mediated amplification of platelet aggregation was ... of exposure ranges that produce minimal, moderate and near-complete inhibition of serotonin-mediated platelet aggregation. These results further ...
... use in humans with advanced RA and other immune mediated diseases. The inhibition of B-cell function and proliferation in the various models, including ... critical enzyme involved in B-cell activation and mast cell function, and inhibition of its function may be useful in the treatment of immune mediated ....
... in relapsed/refractory mantle cell lymphoma and indicate that mTOR inhibition may be a viable approach in this disease area." MCL accounts for ... development of TORISEL. About TORISEL TORISEL is an mTOR inhibitor. inhibition of mTOR in treated cancer cells blocked the translation of genes that ...
... RCC patients. Wyeth is committed to the continued exploration of mTOR inhibition with TORISEL for the treatment of a variety of cancers," says Joseph S. ... development of TORISEL. About TORISEL TORISEL is an mTOR inhibitor. inhibition of mTOR in treated cancer cells blocked the translation of genes that ...
... of energy expenditure and adiposity. Selective inhibition of FGFR4 with antisense drugs in peripheral ... Booten, B.P. Monia, S. Bhanot. Antisense inhibition of cAMP Response Element Binding Protein (CREB) ... Witchell, P. Manchem, S. Bhanot, B.P. Monia. inhibition of Transthyretin Expression by Antisense ...
... May Have Direct Anti-Tumor and Angiogenesis inhibition Activity New York, London and Bermuda, June ... potential anti-tumor and angiogenesis inhibition effects of XERECEPT(R). "The ability to ... models, in addition to assessment of angiogenesis inhibition potential. These placebo-controlled studies were ...
Isis and Collaborators Present New Research at the ATVB Annual Conference
... also presented new research titled "Antisense inhibition of apolipoproteinC-III mitigated features of ... In a presentation titled "Antisense-mediated inhibition of 11 beta-HSD1 significantly decreases hepatic ... from Columbia University , showed that antisense inhibition of 11 beta-HSD1 reduced triglycerides in both ...... a much higher TRAP-induced platelet aggregation inhibition compared to standard of care alone in both ... TRAP-induced platelet aggregation inhibition was also measured. In those receiving the three oral loadings doses, platelet inhibition of greater than or equal to 80 percent was seen ...
... Reversible, High-level Platelet inhibition with Immediate Onset of Action - NEW ORLEANS ... transition to predictable, reversible platelet inhibition in the chronic setting. "Of the millions of ... PRT060128, and achieved the predefined endpoint. inhibition of thrombosis was highly significant in these ...
... patients. Study Results --Leukotriene inhibition The ACS trial demonstrated a statistically ... E4 (LTE4), also showed significant inhibition at all dose levels. The CEA trial confirmed the ... inhibited at 12 weeks (p < 0.001). Leukotriene inhibition was seen early in both trials and was ...
... enhances insulin signaling through potent PTP-1B inhibition both in vivo and in vitro. "The search to ... and safety of MSI-1436 in future studies." inhibition of PTP-1B, a non-receptor isoform of the protein ... obese animal models. The poster described the inhibition of PTP-1B by MSI-1436 as fully reversible and ...
... - First Phase II data investigating the dual inhibition of HER2 and VEGF pathways with two oral, small ... resistance.(4) It is believed that targeted inhibition of several tumor cell signaling pathways may be more effective than inhibition of a single pathway alone.(4) "Targeted ...
Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K/mTOR Inhibitor XL765 at ASCO
... Robust Pathway inhibition in Tumor and Surrogate Tissues at Well-Tolerated ... skin, and peripheral blood cells. The pattern of inhibition of protein phosphorylation observed in ... to play a key role in insulin signaling, and PI3K inhibition has been shown to increase insulin levels in ...... tumors, treatment with PCI-27483 led to inhibition of tumor growth. PCI-27483 was administered twice ... 90 mg/kg, resulting in 42 percent and 85 percent inhibition of tumor growth, respectively, after 15 days of ... Previous work has shown significant growth inhibition in lung and colorectal cancer models. ...
... of HuMax-EGFr (zalutumumab) results in effective inhibition of cancer cell growth. Genmab A/S (OMX: GEN) ... of HuMax-EGFr (zalutumumab) results in effective inhibition of cancer cell growth. As EGFr activity plays ... the structural rearrangement accompanying inhibition of individual EGFr molecules was studied. ...
... but not in normal cells, which then leads to the inhibition of glycolysis selectively in tumor cells. ... within the glycolytic pathway and the inhibition of lactate production. The observed inhibition of glycolysis is a key factor in the energetic ...
... anti-tumor activity through continuous targeted inhibition of mTOR - ... demonstrates the possibilities of continuous mTOR inhibition as a promising target in oncology," said David ... once-daily oral therapy that provides continuous inhibition of mTOR. As an investigational compound, the ...
Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained With Naproxen Sodium
... has confirmed that it does not alter the platelet inhibition of low dose aspirin therapy. This clinical study ... alone. The primary endpoint in the study was the inhibition of TXB2, measured through blood samples that were ... on day 11. The mean (+/- SD) degree of serum TXB2 inhibition was: -- 99.7% (+/- 0.26%) for 81 mg of ...... inhibition Was Sustained and Dose-Dependent in Sub-Analysis ... dose- dependent, specific agonist-induced inhibition of platelet aggregation in blood samples from ... coronary intervention (PCI). "The inhibition of platelet aggregation plays a critical role ...
... and SF1126, as well as synergistic growth inhibition of brain cancer cells with combinations of ... SF1126 and rapamycin showed excellent growth inhibition synergies across all prostate, renal ... as a single agent showed significant tumor growth inhibition relative to the control group (73% inhibition, p ...
... mice resulted in substantial tumor growth inhibition in a statistically-significant dose-related ... as changes in tumor weight, tumor growth inhibition and tumor regression. In all models, NKTR-102 ... at 90 mg/kg resulted in only modest tumor growth inhibition of 6% in colorectal and 24% in lung. In the ...
... to date demonstrate the potential of simultaneous inhibition of MET, RET, and VEGFR, and validate our ability ... in preclinical models has demonstrated potent inhibition of both MET and VEGFR2. XL184 has also exhibited potent inhibition of other important receptor tyrosine kinases ...
Isis Reports Preclinical Data Supporting Liver Safety of ISIS 301012
... animal studies distinguish liver effects of apoB inhibition from MTP inhibition and support liver safety of ISIS 301012 - ... in liver fat metabolism associated with apoB inhibition but not MTP inhibition - ...... as a multitargeted compound, directed to the inhibition of key cell signaling pathways involved in tumor ... and spread. Tumor cells are targeted through inhibition of epidermal growth factor receptor (EGFR) and ... while tumor blood supply is targeted through inhibition of vascular endothelial growth factor receptor ...
Alfacell Provides Shareholder Update
... addition of Onconase to Cisplatin significantly increased the tumor growth inhibition compared to Cisplatin or Onconase alone, and in the tumor model most resistant to platinum, Onconase addition to platinum increased tumor growth inhibition from 37% to 73%. These in vitro and in vivo data, which are ...Neurocrine Biosciences Presents Elagolix Data
... levels and cell immunohistochemistry. The data reveal that transient inhibition of plasma testosterone and intra-prostatic androgens results in the ... If these preclinical results are replicated in men, daily transient inhibition of androgens with a GnRH antagonist may constitute a new paradigm for the ...... selectively targets a subunit of the immunoproteasome, known as LMP7. inhibition of this subunit results in a decrease of the immune cell signaling cascade ... Molineaux, Ph.D., Chief Scientific Officer at Proteolix. "This selective inhibition of the immunoproteasome results in an increased therapeutic margin ...
... outcomes. Pharmacodynamic analysis of tumor tissue confirmed inhibition of the PI3K pathway by complete absence of a downstream target (pS6). In contrast, a normal tissue (skin) demonstrated no inhibition providing evidence of tumor selectivity of SF1126. Pharmacokinetics ...
... in both animal models of ocular disease and in human clinical trials. The inhibition of both TORC1 and TORC2 should result in more complete inhibition of aberrant PI3K/Akt/mTOR signaling and are therefore of active interest ...
... genotype 1. In this study, low doses of ritonavir were used for metabolic inhibition to enhance the levels of SCH 900518 within the body and reduce the ... receiving PEGINTRON/REBETOL combination therapy, weight loss and growth inhibition were common. Patients receiving PEGINTRON and REBETOL as retreatment ...
... for development of a novel therapeutic drug targeting Btk for safe inhibition of B-cell mediated diseases. In preclinical studies, PCI-32765 has the ... is a critical enzyme involved in B-cell activation and function, and inhibition may be useful in the treatment of a number of immune mediated diseases. ...
... small molecule anticancer agent that delivers highly selective and potent inhibition of CK2, a constitutively active protein kinase that is overexpressed in a ... and the data attribute the anti-tumor activity of CX-4945 to intracellular inhibition of the CK2 enzyme. About Cylene Pharmaceuticals, Inc. Cylene ...
... over other anti-platelet agents through immediate, high-level platelet inhibition in the acute setting and a seamless transition to predictable platelet inhibition in the chronic setting. Additionally, due to its reversible binding to ...
... overexpression is a poor prognostic factor. It has been postulated that inhibition of PIM kinase may potentiate the activity of m-tor inhibitors by ... are strong survival factors and can induce progression of the cell cycle, inhibition of apoptosis, and modulation of other signal transduction pathways. ...
... with Dr. Gary Gilkeson's group now show that targeted complement inhibition using TT30 leads to both local control of inflammation as well as a ... in models for several complement-mediated diseases showed that targeted inhibition of the alternative complement pathway slowed or halted disease progression ...
ATL/TV1102 Trial Results Presented at World Congress on Treatment and Research in Multiple Sclerosis
... tissue, for example, the CNS in MS, and the lung airways in asthma. The inhibition of VLA-4 may prevent white blood cells from entering sites of ... VLA-4 is a clinically validated target in the treatment of MS. Antisense inhibition of VLA-4 has demonstrated positive effects in a number of animal models of ...St. Jude Study Finds Treatment With New Drug Might Make Tumor Cells More Sensitive to Therapy
... that leads to irreparable, double-stranded DNA breaks. "We found that inhibition of ATM activity with CP466722 produces cellular effects that are identical ... sensitivity to irradiation, and that after the compound's removal, the inhibition was rapidly and completely reversed. This suggested that a drug based ...Resveratrol Longevity Science Makes Dramatic U-Turn, But Resveratrol Supplements Remain Unchanged
... FOXO1 and PGc1alpha. [Interaction of aging-associated signaling cascades: inhibition of NF-kappaB signaling by longevity factors Foxos and SIRT1. Cell Mol Life ... nude mouse model. Translational Oncology 2008 March; 1(1):19-27; Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with ...... was rapidly absorbed and exposures were related to dose. Dose-dependent inhibition of serotonin-mediated amplification of platelet aggregation was ... of exposure ranges that produce minimal, moderate and near-complete inhibition of serotonin-mediated platelet aggregation. These results further ...
SuperGen's JAK2 Inhibitor, SGI-1252, Inhibits in Vivo Tumor Cell Proliferation
... wildtype and mutant JAK2 activity in cancer cell lines, resulting in inhibition of STAT5 phosphorylation as well as a reduction in Bcl-XL expression. ... is orally bioavailable. "SGI-1252 has shown potent and selective inhibition of JAK2 cellular signaling pathways that are involved in cancer cell ...... use in humans with advanced RA and other immune mediated diseases. The inhibition of B-cell function and proliferation in the various models, including ... critical enzyme involved in B-cell activation and mast cell function, and inhibition of its function may be useful in the treatment of immune mediated ....
... in relapsed/refractory mantle cell lymphoma and indicate that mTOR inhibition may be a viable approach in this disease area." MCL accounts for ... development of TORISEL. About TORISEL TORISEL is an mTOR inhibitor. inhibition of mTOR in treated cancer cells blocked the translation of genes that ...
... RCC patients. Wyeth is committed to the continued exploration of mTOR inhibition with TORISEL for the treatment of a variety of cancers," says Joseph S. ... development of TORISEL. About TORISEL TORISEL is an mTOR inhibitor. inhibition of mTOR in treated cancer cells blocked the translation of genes that ...
Other ContentsheterotrophtagtagtagtagtagtagtagtaghishishishishishishishishishistonehistonehistonehistonehistonehistonehomeoboxhomeostasishomeostasishomeostasishomeostasisOther TagsTonesTones
(Date:12/3/2009)...llers must be included in the design of the upcomi...umanitarian crisis, according to a scientist at th...re , Dr Simon Lewis argues that at least 50% of th...n, known as REDD (Reducing Emissions from Deforest...wellers directly, and their property rights assure...
(Date:12/2/2009)...PHIA Children exposed to secondhand cigarette smo...r in adulthood, even if they never smoked. , Re...miology, Biomarkers & Prevention , a journal of th...t of a special tobacco focus in the December issue...s will be diagnosed with lung cancer; more than 15...
(Date:12/2/2009)...PHIA Mexican-American adolescents exposed to ciga...pick up the habit themselves, and this may be part...ing initiation, according to new study findings. ,...the United States and highlights the global implem...k Convention on Tobacco Control, which includes gu...
Breaking Biology News(10 mins):Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Watching movies featuring characters who smoke negatively influences Mexican-American teens 2Researchers determine predicting factors of positive lung cancer diagnoses in chest radiographs 47488 1Findings in epilepsy gene in animals may guide treatment directions for infants 47484 1Findings in epilepsy gene in animals may guide treatment directions for infants 47484 2Findings in epilepsy gene in animals may guide treatment directions for infants 47484 3Protein linked to mental retardation controls synapse maturation plasticity CSHL team finds 8676 1Protein linked to mental retardation controls synapse maturation plasticity CSHL team finds 8676 2Protein linked to mental retardation controls synapse maturation plasticity CSHL team finds 8676 3(Date:12/4/2009)...nhibOx, a leading developer of novel and effective...ned forces with MolPort, an innovator in rare chem...hemical trading platform and builds database of co...s database and its updates to computational chemis...irtual screening procedures. Once they identify su...
(Date:12/4/2009)...st-Selling author and Personal & Organizationa...Transformation through Accountability! , ...4, 2009 -- IMPAQ Accountability Business Consult...est-selling Author, renowned Speaker, and CEO &...ants Inc., will present at the 14th International ...
(Date:12/3/2009)...iropractic Traffic has gotten into the holiday spi...rketing tool. $1 gets chiropractors 3 months of un... Traffic is even including chiropractic promotiona... (PRWEB) December 3, 2009 -- Chiropractic Marke...tool. Chiropractic Marketing expertise provided b...
(Date:12/3/2009)...., Dec. 3 The development of Unive...MCPP) reached a milestone today with a "topping ou... construction at the new hospital that will replac..., (Photo: http://www.newscom.com/cgi-bin/prnh/... a steelworkers, tradition in which a steel beam c...
(Date:12/3/2009)... The American Medical A...tates District Court for the Southern District of ...reviously disclosed $350 million settlement that w...Health Group. ,, The action brought by the AMA,...ouri State Medical Association, along with several...
Breaking Medicine News(10 mins):Health News:InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery 2Health News:InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery 3Health News:Mark Samuel, CEO & Founder, IMPAQ Accountability Business Consultants Inc., to Present at 14th ICF Annual International Conference 2Health News:New Chiropractic Marketing: A $1 Chiropractic Marketing Tool that Can Make Users $1000s 2Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 2Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 3Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 4Health News:Settlement in AMA Lawsuit against UnitedHealth Gets Preliminary Approval from Federal Court 2[0] InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery [1] Mark Samuel, CEO & Founder, IMPAQ Accountability Business Consultants Inc., to Present at 14th ICF Annual International Conference [0] New Chiropractic Marketing: A $1 Chiropractic Marketing Tool that Can Make Users $1000s[0] 'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro[0] Settlement in AMA Lawsuit against UnitedHealth Gets Preliminary Approval from Federal Court
RyansWashroomVirginiansTonesOmitUndernourishmentDeformabilityMidnightKateeNeedlessHamperingDevaluedMarginalisedScreaming
Other Tagsfish 2fish 3fish 4fish 5fish 6fish 7fish 8fish 9fish 10vision 2vision 3vision 4vision 5vision 6vision 7vision 8vision 9vision 10oils 2oils 3oils 4oils 5fats 2fats 3fats 4fats 5fats 6fats 7fats 8fats 9ring 2ring 3comparison 2comparison 3comparison 4comparison 5comparison 6comparison 7turn 2turn 3turn 4turn 5turn 6turn 7turn 8turn 9turn 10
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |